Attachment 2 60-day FRN

Save As...

Reset

Federal Register / Vol. 76, No. 29 / Friday, February 11, 2011 / Notices
provides for the formation of PSO5,
which collect, aggregate, and analyze
confidential information regarding the
quality and safety of health care
delivery. The Patient Safety and Quality
Improvement Final Rule (Patient Safety
Rule), 42 CFR part 3, authorizes AHRQ,
on behalf of the Secretary of HHS, to list
as a PSO an entity that attests that it
meets the statutory and regulatory
requirements for listing. A PSO can be
‘‘delisted’’ by the Secretary if it is found
to no longer meet the requirements of
the Patient Safety Act and Patient Safety
Rule, including when a PSO chooses to
voluntarily relinquish its status as a
PSO for any reason.
DATES: The directories for both listed
and delisted PSOs are ongoing and
reviewed weekly by AHRQ. The
delisting was effective at 12 Midnight
ET (2400) on December 7, 2010.
ADDRESSES: Both directories can be
accessed electronically at the following
HHS Web site: http://www.pso.
AHRQ.gov/index.html.
FOR FURTHER INFORMATION CONTACT:
Diane Cousins, RPh., Center for Quality
Improvement and Patient Safety, AHRQ,
540 Gaither Road, Rockville, MD 20850;
Telephone (toll free): (866) 403–3697;
Telephone (local): (301) 427–1111; TTY
(toll free): (866) 438–7231; TTY (local):
(301) 427–1130; E-mail: pso@AHRQ.
hhs.gov.
SUPPLEMENTARY INFORMATION:

jlentini on DSKJ8SOYB1PROD with NOTICES

Background
The Patient Safety Act authorizes the
listing of PSOs, which are entities or
component organizations whose
mission and primary activity is to
conduct activities to improve patient
safety and the quality of health care
delivery. HHS issued the Patient Safety
Rule to implement the Patient Safety
Act. AHRQ administers the provisions
of the Patient Safety Act and Patient
Safety Rule (PDF file, 450 KB. PDF
Help) relating to the listing and
operation of PSOs. Section 3.108(d) of
the Patient Safety Rule requires AHRQ
to provide public notice when it
removes an organization from the list of
Federally approved PSOs. AHRQ has
accepted a notification from Lumetra
PSO, a component entity of Lumetra
Healthcare Solutions, PSO number
P0033, to voluntarily relinquish its
status as a PSO. Accordingly, Lumetra
PSO, a component entity of Lumetra
Healthcare Solutions, was delisted
effective at 12 Midnight ET (2400) on
December 7, 2010. More information on
PSOs can be obtained through AHRQ’s
P50 Web site at http://www.pso.
AHRQ.gov/index.html.

VerDate Mar<15>2010

18:55 Feb 10, 2011

Save As...

Jkt 223001

Dated: January 28, 2011.
Carolyn M. Clancy,
Director.
[FR Doc. 2011–2912 Filed 2–10–11; 8:45 am]
BILLING CODE 4160–90–M

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Patient Safety Organizations:
Voluntary Delisting From Community
Medical Foundation for Patient Safety
Agency for Healthcare Research
and Quality (AHRQ), HHS.
ACTION: Notice of Delisting.
AGENCY:

Community Medical
Foundation for Patient Safety: AHRQ
has accepted a notification of voluntary
relinquishment from Community
Medical Foundation for Patient Safety,
of its status as a Patient Safety
Organization (PSO). The Patient Safety
and Quality Improvement Act of 2005
(Patient Safety Act), Public Law 109–
41,42 U.S.C. 299b–21—b–26, provides
for the formation of PSOs, which
collect, aggregate, and analyze
confidential information regarding the
quality and safety of health care
delivery. The Patient Safety and Quality
Improvement Final Rule (Patient Safety
Rule), 42 CFR Part 3, authorizes AHRQ,
on behalf of the Secretary of HHS, to list
as a PSO an entity that attests that it
meets the statutory and regulatory
requirements for listing. A PSO can be
‘‘delisted’’ by the Secretary if it is found
to no longer meet the requirements of
the Patient Safety Act and Patient Safety
Rule, including when a PSO chooses to
voluntarily relinquish its status as a
PSO for any reason.
DATES: The directories for both listed
and delisted PSOs are ongoing and
reviewed weekly by AHRQ. The
delisting was effective at 12 Midnight
ET (2400) on December 22, 2010.
ADDRESSES: Both directories can be
accessed electronically at the following
HHS Web site: http://
www.pso.AHRQ.gov/index.html.
FOR FURTHER INFORMATION CONTACT:
Diane Cousins, RPh., Center for Quality
Improvement and Patient Safety, AHRQ,
540 Gaither Road, Rockville, MD 20850;
Telephone (toll free): (866) 403–3697;
Telephone (local): (301) 427–1111; TTY
(toll free): (866) 438–7231; TTY (local):
(301) 427–1130; E-mail:
[email protected].
SUMMARY:

SUPPLEMENTARY INFORMATION:

PO 00000

Frm 00049

Fmt 4703

Sfmt 4703

7855

Background
The Patient Safety Act authorizes the
listing of PSOs, which are entities or
component organizations whose
mission and primary activity is to
conduct activities to improve patient
safety and the quality of health care
delivery. HHS issued the Patient Safety
Rule to implement the Patient Safety
Act. AHRQ administers the provisions
of the Patient Safety Act and Patient
Safety Rule (PDF file, 450 KB. PDF
Help) relating to the listing and
operation of PSOs. Section 3.108(d) of
the Patient Safety Rule requires AHRQ
to provide public notice when it
removes an organization from the list of
federally approved PSOs. AHRQ has
accepted a notification from Community
Medical Foundation for Patient Safety,
PSO number P0029, to voluntarily
relinquish its status as a PSO.
Accordingly, Community Medical
Foundation for Patient Safety was
delisted effective at 12 Midnight ET
(2400) on December 22, 2010.
More information on PSOs can be
obtained through AHRQ’s PSO Web site
at http://www.pso.AHRQ.gov/
index.html.
Dated: January 28, 2011.
Carolyn M. Clancy,
Director.
[FR Doc. 2011–2910 Filed 2–10–11; 8:45 am]
BILLING CODE 4160–90–M

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–11–0026]

Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 and
send comments to Carol E. Walker, CDC
Acting Reports Clearance Officer, 1600
Clifton Road, MS–D74, Atlanta, GA
30333 or send an e-mail to
[email protected].
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance

E:\FR\FM\11FEN1.SGM

11FEN1

Save As...

7856

Federal Register / Vol. 76, No. 29 / Friday, February 11, 2011 / Notices
State and Territorial Epidemiologists,
and the Advisory Committee for the
Elimination of Tuberculosis. No
revisions to the RVCT are proposed in
this data collection extension request.
CDC publishes an annual report using
RVCT data to summarize national TB
statistics and also periodically conducts
special analyses for publication to
further describe and interpret national
TB data. These data assist in public
health planning, evaluation, and
resource allocation. Reporting areas also
review and analyze their RVCT data to
monitor local TB trends, evaluate
program success, and focus resources to
eliminate TB. No other Federal agency
collects this type of national TB data. In
addition to providing technical
assistance on the use of RVCT, CDC
provides technical support for reporting
software.
In this request, CDC is requesting
approval for approximately 6,720
burden hours, an estimated decrease of
1,330 hours. This decrease is due to
having fewer TB cases in the United
States as we continue progress towards
TB elimination. There is no cost to
respondents except for their time.

in their lives. The purpose of this
project is to continue ongoing national
tuberculosis surveillance using the
standardized Report of Verified Case of
Tuberculosis (RVCT). Data collected
using the RVCT help State and Federal
infectious disease officials to assess
changes in the diagnosis and treatment
of TB, monitor trends in TB
epidemiology and outbreaks, and
develop strategies to meet the national
goal of TB elimination.
CDC currently conducts and
maintains the national surveillance
system pursuant to the provisions of
section 301(a) of the Public Service Act
[42 U.S.C. 241] and section 306 of the
Public Service Act [42 U.S.C. 241(a)].
Data are collected by 60 reporting areas
(the 50 States, the District of Columbia,
New York City, Puerto Rico, and 7
jurisdictions in the Pacific and
Caribbean). The last major revision of
the RVCT data collection instrument
was approved in 2008, in consultation
with CDC’s Division of Tuberculosis
Elimination (DTBE), State and local
health departments, and partner
organizations including the National TB
Controllers Association, the Council for

of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information;
(c) ways to enhance the quality, utility,
and clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Report of Verified Case of
Tuberculosis (RVCT), (OMB No.0920–
0026 exp. 5/31/2011)—Extension—
National Center for HIV/AIDS, Viral
Hepatitis, STD, and TB Prevention
(NCHHSTP), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
In the United States, an estimated 10
to 15 million people are infected with
Mycobacterium tuberculosis and about
10% of these persons will develop
tuberculosis (TB) disease at some point

ESTIMATE OF ANNUALIZED BURDEN HOURS
Number of
respondents

Types of respondents

Average
burden
response (in
hours)

Total burden
(in hours)

Local, State, and territorial health departments ..............................................

60

192

35/60

6,720

Total ..........................................................................................................

........................

........................

........................

6,720

Dated: February 4, 2011.
Carol E. Walker,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. 2011–3079 Filed 2–10–11; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–11–11CC]

Proposed Data Collections Submitted
for Public Comment and
Recommendations
jlentini on DSKJ8SOYB1PROD with NOTICES

Number of
responses per
respondent

In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic

VerDate Mar<15>2010

18:55 Feb 10, 2011

Save As...

Jkt 223001

summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 or send
comments to Carol E. Walker, CDC
Acting Reports Clearance Officer, 1600
Clifton Road, MS D–74, Atlanta, GA
30333 or send an e-mail to
[email protected].
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information;
(c) ways to enhance the quality, utility,
and clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should

PO 00000

Frm 00050

Fmt 4703

Sfmt 4703

be received within 60 days of this
notice.
Proposed Project
Development and Evaluation of Eagle
Books and Youth Eagle Books for
American Indians and Alaska Natives
(AI/ANs)—New—National Center for
Chronic Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The development of effective diabetes
prevention programs targeting AI/AN
youth is a compelling priority in
education and public health. AI/ANs
develop type 2 diabetes at younger ages,
experience more years of disease burden
and have a high probability of
developing diabetes-related
complications. However, research
shows that type 2 diabetes can be
prevented or delayed with healthy
foods, moderate physical activity, and
social support. A number of health

E:\FR\FM\11FEN1.SGM

11FEN1